Skip to content

HOMOEOPATHIC MEDICINES IN DELUSIONAL DISORDER

EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN TREATMENT OF DELUSIONAL DISORDER

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046547
Enrollment
33
Registered
2022-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F22- Delusional disorders

Interventions

Intervention1: HOMOEOPATHIC MEDICINE: Individualised Homoeopathic medicines prescribed according to Homoeopathic principles. Route of administration - oral as per requirement. Frequency- as per requir

Sponsors

DR L SAROJINI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases satisfying Delusional disorder (F22) diagnostic criteria of DSM-V,Age group between 18 to 70 years

Exclusion criteria

Exclusion criteria: Organic delusional disorder, Induced delusional disorder, or any other psychiatric comorbidity. Subjects who used psychotropic medicines in the past two weeks. Subjects who are pregnant or lactating Severe systemic illness using conventional treatment. Immuno-compromised conditions like HIV, Tuberculosis etc

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness of Individualized Homoeopathic medicines in reducing symptoms of Delusional Disorder using Brownâ??s Assessment of Belief ScaleTimepoint: 6 months for enrollment 1 year for followup

Secondary

MeasureTime frame
1. To determine the effectiveness of Individualized Homoeopathic medicines in reducing delusional conviction using Conviction of Delusional Belief Scale (CDBS) 2. To find out changes in disability of patient with respect to the Homoeopathic medicines using WHO-DAS 2.0Timepoint: 6 months for enrollment 1 year for followup

Countries

India

Contacts

Public ContactDR DEEPTHI GILLA

National Homoeopathy Research Institute In Mental Health

drdeepthigilla@gmail.com8111990221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026